Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
Clinical trial NCT04806451 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04806451
- Sponsor
- Neurocrine Biosciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-03-10
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.